Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

SPOILER ALERT: This article contains major spoilers for “Avatar: Fire and Ash,” now playing in theaters. Director James Cameron is back with biggest and longest “Avatar” movie yet, “Fire and Ash.” ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Spoiler alert! The following post contains major details about the ending of “The Housemaid” (in theaters now). Stop reading now if you haven’t seen it and don’t want to know. In “The Housemaid,” ...

Spoilers for Season 5 of "Emily in Paris" ahead. From Rome to Paris to Venice and back to the City of Light, Season 5 of "Emily in Paris" takes viewers on a whirlwind European adventure. The hit ...

The finale goes to the dogs, quite literally, when it opens with Homo Aqua luring pooches out of their houses into the sea. Like a canine Weapons, if you will. The fish people point out that if humans ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, TheFly reported that Cathie Wood’s ARK Investment has ...

) has been revised to $7.14 / share. This is an increase of 10.53% from the prior estimate of $6.46 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...

The ending of ‘Avatar: Fire and Ash’ hints at sequels, with the villain’s story left unresolved and Kiri still uncovering her connection to Eywa. ByDani Di Placido, Senior Contributor. Forbes ...